388 related articles for article (PubMed ID: 26743035)
1. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes.
Funakoshi S; Miki K; Takaki T; Okubo C; Hatani T; Chonabayashi K; Nishikawa M; Takei I; Oishi A; Narita M; Hoshijima M; Kimura T; Yamanaka S; Yoshida Y
Sci Rep; 2016 Jan; 6():19111. PubMed ID: 26743035
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction.
Ong SG; Huber BC; Lee WH; Kodo K; Ebert AD; Ma Y; Nguyen PK; Diecke S; Chen WY; Wu JC
Circulation; 2015 Aug; 132(8):762-771. PubMed ID: 26304668
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
[TBL] [Abstract][Full Text] [Related]
4. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
Cheng YC; Hsieh ML; Lin CJ; Chang CMC; Huang CY; Puntney R; Wu Moy A; Ting CY; Herr Chan DZ; Nicholson MW; Lin PJ; Chen HC; Kim GC; Zhang J; Coonen J; Basu P; Simmons HA; Liu YW; Hacker TA; Kamp TJ; Hsieh PCH
Circulation; 2023 Oct; 148(18):1395-1409. PubMed ID: 37732466
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium.
Liu Z; Wen X; Wang H; Zhou J; Zhao M; Lin Q; Wang Y; Li J; Li D; Du Z; Yao A; Cao F; Wang C
PLoS One; 2013; 8(6):e66369. PubMed ID: 23840453
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.
Zhao M; Nakada Y; Wei Y; Bian W; Chu Y; Borovjagin AV; Xie M; Zhu W; Nguyen T; Zhou Y; Serpooshan V; Walcott GP; Zhang J
Circulation; 2021 Jul; 144(3):210-228. PubMed ID: 33951921
[TBL] [Abstract][Full Text] [Related]
7. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart.
Higuchi T; Miyagawa S; Pearson JT; Fukushima S; Saito A; Tsuchimochi H; Sonobe T; Fujii Y; Yagi N; Astolfo A; Shirai M; Sawa Y
Cell Transplant; 2015; 24(12):2479-89. PubMed ID: 25606821
[TBL] [Abstract][Full Text] [Related]
8. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
[TBL] [Abstract][Full Text] [Related]
9. Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients.
Lepperhof V; Polchynski O; Kruttwig K; Brüggemann C; Neef K; Drey F; Zheng Y; Ackermann JP; Choi YH; Wunderlich TF; Hoehn M; Hescheler J; Sarić T
PLoS One; 2014; 9(9):e107363. PubMed ID: 25226590
[TBL] [Abstract][Full Text] [Related]
10. Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2.
Hatani T; Funakoshi S; Deerinck TJ; Bushong EA; Kimura T; Takeshima H; Ellisman MH; Hoshijima M; Yoshida Y
Biochem Biophys Res Commun; 2018 Nov; 505(4):1251-1256. PubMed ID: 30333092
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.
Fan C; Fast VG; Tang Y; Zhao M; Turner JF; Krishnamurthy P; Rogers JM; Valarmathi MT; Yang J; Zhu W; Zhang J
J Mol Cell Cardiol; 2019 Dec; 137():25-33. PubMed ID: 31629738
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
Rojas SV; Kensah G; Rotaermel A; Baraki H; Kutschka I; Zweigerdt R; Martin U; Haverich A; Gruh I; Martens A
PLoS One; 2017; 12(5):e0173222. PubMed ID: 28493867
[TBL] [Abstract][Full Text] [Related]
13. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
[TBL] [Abstract][Full Text] [Related]
14. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
[TBL] [Abstract][Full Text] [Related]
15. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
[No Abstract] [Full Text] [Related]
16. Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin.
Tanaka Y; Kadota S; Zhao J; Kobayashi H; Okano S; Izumi M; Honda Y; Ichimura H; Shiba N; Uemura T; Wada Y; Chuma S; Nakada T; Tohyama S; Fukuda K; Yamada M; Seto T; Kuwahara K; Shiba Y
Stem Cell Res Ther; 2023 Sep; 14(1):240. PubMed ID: 37679796
[TBL] [Abstract][Full Text] [Related]
17. Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice.
Mattapally S; Zhu W; Fast VG; Gao L; Worley C; Kannappan R; Borovjagin AV; Zhang J
Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H327-H339. PubMed ID: 29631371
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.
Shiba Y; Gomibuchi T; Seto T; Wada Y; Ichimura H; Tanaka Y; Ogasawara T; Okada K; Shiba N; Sakamoto K; Ido D; Shiina T; Ohkura M; Nakai J; Uno N; Kazuki Y; Oshimura M; Minami I; Ikeda U
Nature; 2016 Oct; 538(7625):388-391. PubMed ID: 27723741
[TBL] [Abstract][Full Text] [Related]
19. In vivo differentiation of induced pluripotent stem cell-derived cardiomyocytes.
Yu T; Miyagawa S; Miki K; Saito A; Fukushima S; Higuchi T; Kawamura M; Kawamura T; Ito E; Kawaguchi N; Sawa Y; Matsuura N
Circ J; 2013; 77(5):1297-306. PubMed ID: 23392122
[TBL] [Abstract][Full Text] [Related]
20. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
